Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures

被引:13
作者
Amano, Yohei [1 ]
Noguchi, Masayuki [1 ]
Nakagomi, Madoka [1 ]
Muratake, Hideaki [1 ]
Fukasawa, Hiroshi [1 ]
Shudo, Koichi [1 ]
机构
[1] Res Fdn Itsuu Lab, Setagaya Ku, Tokyo 1580094, Japan
关键词
Retinoid; RAR; Agonist; Bulky hydrophobic fragment; Amide; PROMYELOCYTIC LEUKEMIA-CELLS; DIFFERENT NUCLEAR RECEPTORS; UNION-OF-PHARMACOLOGY; ACID RECEPTOR; RETINOBENZOIC ACIDS; ALZHEIMERS-DISEASE; X-RECEPTORS; ALPHA; MOUSE; GAMMA;
D O I
10.1016/j.bmc.2013.04.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many synthetic retinoids contain an aromatic structure with a bulky hydrophobic fragment. In order to obtain retinoids with therapeutic potential that do not bind to or activate retinoic acid X receptors (RXRs), we focused on the introduction of novel hydrophobic moieties, that is, metacyclophane, phenalene and benzoheptalene derivatives. The designed compounds were synthesized and their agonistic activities towards RARs and RXRs were evaluated. Most of the active compounds showed selectivity for RAR alpha and RAR beta over RAR gamma, and higher RAR beta transactivating activity seemed to correlate with higher cell differentiation-inducing activity towards promyelocytic leukemia cell line HL-60. These compounds showed no agonistic activity towards RXRs. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4342 / 4350
页数:9
相关论文
共 46 条
[1]  
ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625
[2]   RETINOIC ACID RECEPTORS AND RETINOID X-RECEPTORS - INTERACTIONS WITH ENDOGENOUS RETINOIC ACIDS [J].
ALLENBY, G ;
BOCQUEL, MT ;
SAUNDERS, M ;
KAZMER, S ;
SPECK, J ;
ROSENBERGER, M ;
LOVEY, A ;
KASTNER, P ;
GRIPPO, JF ;
CHAMBON, P ;
LEVIN, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :30-34
[3]   Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor [J].
Altucci, L ;
Rossin, A ;
Hirsch, O ;
Nebbioso, A ;
Vitoux, D ;
Wilhelm, E ;
Guidez, F ;
De Simone, M ;
Schiavone, EM ;
Grimwade, D ;
Zelent, A ;
de Thé, H ;
Gronemeyer, H .
CANCER RESEARCH, 2005, 65 (19) :8754-8765
[4]   All-trans-Retinoic Acid Represses Obesity and Insulin Resistance by Activating both Peroxisome Proliferation-Activated Receptor β/δ and Retinoic Acid Receptor [J].
Berry, Daniel C. ;
Noy, Noa .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (12) :3286-3296
[5]   Overview of retinoid metabolism and function [J].
Blomhoff, Rune ;
Blomhoff, Heidi Kiil .
JOURNAL OF NEUROBIOLOGY, 2006, 66 (07) :606-630
[6]   ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models [J].
Cramer, Paige E. ;
Cirrito, John R. ;
Wesson, Daniel W. ;
Lee, C. Y. Daniel ;
Karlo, J. Colleen ;
Zinn, Adriana E. ;
Casali, Brad T. ;
Restivo, Jessica L. ;
Goebel, Whitney D. ;
James, Michael J. ;
Brunden, Kurt R. ;
Wilson, Donald A. ;
Landreth, Gary E. .
SCIENCE, 2012, 335 (6075) :1503-1506
[7]   Design of selective nuclear receptor modulators: RAR and RXR as a case study [J].
de Lera, Angel R. ;
Bourguet, William ;
Altucci, Lucia ;
Gronemeyer, Hinrich .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :811-820
[8]  
DETHE H, 1992, CANCER SURV, V14, P195
[9]   Tamibarotene: A Candidate Retinoid Drug for Alzheimer's Disease [J].
Fukasawa, Hiroshi ;
Nakagomi, Madoka ;
Yamagata, Naoko ;
Katsuki, Hiroshi ;
Kawahara, Kohichi ;
Kitaoka, Kazuyoshi ;
Miki, Takami ;
Shudo, Koichi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (08) :1206-1212
[10]   International Union of Pharmacology. LX. Retinoic acid receptors [J].
Germain, Pierre ;
Chambon, Pierre ;
Eichele, Gregor ;
Evans, Ronald M. ;
Lazar, Mitchell A. ;
Leid, Mark ;
De Lera, Angel R. ;
Lotan, Reuben ;
Mangelsdorf, David J. ;
Gronemeyer, Hinrich .
PHARMACOLOGICAL REVIEWS, 2006, 58 (04) :712-725